retatrutide side effects clinical trial results 2024 2025 Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Understanding Retatrutide: Safety and Risks

The future of GLP-1 use in type 1 diabetes hinges on several evolving factors: Ongoing research to clarify safety and efficacy in type 1 diabetes

Using the Wrong Water: Using sterile water and then storing the vial for weeks is asking for bacterial growth

Start two or three nights a week and build up, and always patch-test a new serum on your inner forearm first

While the ADA recommends considering a GLP-1 receptor agonist or the addition of mealtime insulin, 3 the AACE/ACE algorithm additionally recommends SGLT-2 inhibitors and DPP-4 inhibitors as potential therapies that can be added to basal insulin, if they are not already incorporated into the medication regimen

Key molecular mechanisms include mitochondrial reverse electron transport activation induced by mutant proto-oncogenes KRAS/BRAF [385], oxidative inactivation of DNA repair enzymes leading to mutation accumulation [386], and constitutive activation of NRF2 pathway [387]